logo
logo
AI-POWERED SIGNALS

Real Signals. Real Leads. Real Deals.

The only platform that turns real-time signals into your perfect leads

Know Who, Why, and When to reach out — instantly.

FundzWatch™ AI Scoring
10-25 leads daily
Real-time alerts
★★★★★
4.8/5 on G2• High Performer Fall 2025
Used by teams at LinkedIn, HubSpot & Oracle
🔒 app.fundz.net

SEALSQ Corp

📍 British Virgin Islands👥 67
78
High Intent
⭐ Ideal Match

Multiple growth signals indicate buying readiness

Bluesight acquires Sectyr to expand 340B audit and compliance tools for health systems

Oct 17, 2024•11 months ago

Acquiring Company

Bluesight

Acquired Company

Sectyr

AlexandriaScottsdaleMachine LearningArtificial IntelligenceHealth CareAnalyticsHealth Care

Description

Bluesight, the leading provider of Medication Intelligence™ solutions, has acquired Sectyr, a top-tier compliance and audit management platform. This acquisition expands Bluesight's portfolio to include robust 340B audit and compliance tools, reinforcing its mission of empowering healthcare organizations to ensure medication safety, compliance, and operational efficiency.

Company Information

Company

Bluesight

Location

Alexandria, Virginia, United States

About

Bluesight solves supply chain inefficiencies and reduces risk by using AI and machine learning to surface actionable analytics for every step of the medication lifecycle. Through our suite of Medication IntelligenceTM solutions, Bluesight brings simplicity, visibility, and predictability to the complex world of medication management. More than 1,600 U.S. and Canadian hospitals utilize Bluesight solutions to optimize their hospital pharmacy practices by improving efficiency, reducing medication costs, and increasing compliance and safety.

Company News

(10 articles)
Wed, 06 Aug 2025 07:00:00 GMT

New Bluesight Report Details How Hospitals Are Modernizing Pharmacy Purchasing - PR Newswire

Tue, 19 Aug 2025 07:00:00 GMT

Bluesight Launches Predictive Shortage Mitigation Solution - PR Newswire

Wed, 06 Aug 2025 07:00:00 GMT

Bluesight Releases 2025 Hospital Pharmacy Drug Purchasing Trends Report - HIT Consultant

Mon, 05 Dec 2022 08:00:00 GMT

Medication Intelligence Leader Kit CheckⓇ Rebrands as BluesightⓇ - Business Wire

Mon, 17 Jul 2023 07:00:00 GMT

Thoma Bravo merging Bluesight, Medacist - Axios

Sun, 16 Jul 2023 07:00:00 GMT

Thoma Bravo makes healthcare play with Bluesight investment - PitchBook

Fri, 08 Sep 2023 07:00:00 GMT

Private equity healthcare acquisitions – July 2023 - Private Equity Stakeholder Project PESP

Tue, 06 Dec 2022 08:00:00 GMT

New Report from BluesightⓇ Sheds Light on U.S. Consumer Trust in Healthcare and Pharmaceutical Management - Business Wire

Thu, 09 Jan 2025 08:00:00 GMT

Bluesight Expands Compliance Capabilities and Strengthens Platform through Acquisition of Protenus - PR Newswire

Mon, 17 Jul 2023 07:00:00 GMT

Thoma Bravo Announces Strategic Growth Investment in Bluesight to Support the Company's Acquisition of Medacist - PR Newswire

FundzWatch™ Score

86
High M&A Activity

Related People

Sign in to view contact details

Sign in to view contact details

M&A Insights

Based on deal data
Integration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed